Search

Search Funnelback University

Search powered by Funnelback
21 - 30 of 59 search results for TALK:PC53 20 |u:www.ubs.admin.cam.ac.uk where 0 match all words and 59 match some words.
  1. Results that match 1 of 2 words

  2. AOC Minutes 20th October 2023

    https://www.ubs.admin.cam.ac.uk/system/files/public/aoc_minutes_201023_redacted.pdf
    14 May 2024: Minutes. Date: Friday, 20/10/2023 Time: 1.30pm To: Committee Members At: Subject: AWERB Operations Committee.
  3. 3Rs Minutes 4th November 2020 Redacted

    https://www.ubs.admin.cam.ac.uk/system/files/public/3rs_minutes_041120_redacted.pdf
    14 May 2024: licence. Page 4 of 4. • Protocol 9 The committee suggest additional wording is added to the adverse effects section where weight loss of up to 20% after arterial cannulation is written.
  4. AOC Minutes 26th November 2021

    https://www.ubs.admin.cam.ac.uk/system/files/public/aoc_minutes_26.11.21_redacted.pdf
    14 May 2024: 7. Good practice; training and competencies The cut-off date for the next IAT term is the 20 h December.
  5. In vivo compressive forces (non-technical summary)_Redacted

    https://www.ubs.admin.cam.ac.uk/system/files/public/in_vivo_compressive_forces_non-technical_summary_redacted.pdf
    30 Apr 2024: We estimate that carrying out this work in culture will reduce our anticipated animal usage by roughly 20%. ... We will maintain 20 existing transgenic lines and two wild type lines and generate ten new transgenic lines (80x32 lines=2560 fish).
  6. Embryonic origins of heart disease

    https://www.ubs.admin.cam.ac.uk/system/files/public/embryonic_origins_of_heart_disease_non-technical_summary_redacted.pdf
    29 Apr 2024: at day 20 out of 21-day incubation period). The majority of the studies will be ex vivo (after death), i.e. ... it decreases fetal body weight by 20% by the end of the incubation period.
  7. Molecular mechanisms of tolerance and immunosuppression…

    https://www.ubs.admin.cam.ac.uk/system/files/public/molecular_mechanisms_of_tolerance_and_immunosuppression_non-technical_summary_redacted.pdf
    30 Apr 2024: PPL number: | Granted: 20 Apr 23 | Amended: 24 Aug 23 | Expires: 20 Apr 28. ... A retrospective assessment of these aims will be due by 20 October 2028.
  8. Platelets as a therapeutic tool

    https://www.ubs.admin.cam.ac.uk/system/files/public/platelets_as_a_therapeutic_tool_non-technical_summary_redacted.pdf
    30 Apr 2024: Animals that have a loss of body weight of 20% relative to the baseline will be killed by a Schedule 1 method. ... altered bowel movements. Weight loss 10-20% of control animals. 3. Marked increase in body temperature, respiration noisy, comatose OR
  9. Models of mitochondrial diseases, pathogenesis and therapy

    https://www.ubs.admin.cam.ac.uk/system/files/public/models_of_mitochondrial_diseases_pathogenesis_and_therapy_non-technical_summary_redacted.pdf
    30 Apr 2024: The remaining 20% will be neonates (new born pups up to weaning - approx. ... Animals experiencing Moderate severity will be closely monitored for weight loss (to gauge the impact of the abnormal movement on their ability to feed) and will be killed
  10. Proteotoxicity in development and ageing (non-technical…

    https://www.ubs.admin.cam.ac.uk/system/files/public/proteotoxicity_in_development_and_ageing_non-technical_summary_redacted.pdf
    30 Apr 2024: Mice:. 1) Mild 60%. 2) Sub-threshold 20%. 3) Moderate 20%. What will happen to animals at the end of this project?
  11. Understanding the cell biology behind cardiovascular diseases…

    https://www.ubs.admin.cam.ac.uk/system/files/public/understanding_the_cell_biology_behind_cardiovascular_diseases_non-technical_summary_redacted.pdf
    30 Apr 2024: Route Daily vol. ml/kg Max. No./day Max. No. of doses. oral gavage 20 ml/kg 2 30. ... intraperitoneal 20 ml/kg 1 30. intravenous 10 ml/kg 1 14. intramuscular 10–50 µl 1 6.

Refine your results

Format

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.